Skip to content

Age-Related Macular Degeneration (AMD) Research using AREDS dataset provided by National Institute of Health (NIH).

Notifications You must be signed in to change notification settings

arundasan91/Macular-Degeneration

Folders and files

NameName
Last commit message
Last commit date

Latest commit

 

History

20 Commits
 
 
 
 
 
 
 
 
 
 

Repository files navigation

Distributed machine learning cloud teleophthalmology IoT for predicting AMD disease progression

Arun Das, Paul Rad, Kim-Kwang Raymond Choo, Babak Nouhi, Jonathan Lish, James Martel

Macular-Degeneration

Age-Related Macular Degeneration (AMD) Research using AREDS dataset provided by National Institute of Health (NIH).

Research Question: Developing Deep Learning algorithms for grading AMD into four severity categories.

Picture Ref: JAMA Severity Categories

Age-Related Macular Degeneration (AMD) Categories

Ref: ncbi.nlm.nih.gov

AMD Category 1.

Each eye has:

  • No drusen or small, nonextensive drusen
  • No intermediate drusen
  • No large drusen
  • No pigment abnormalities
  • No advanced AMD
  • A visual acuity score of 74 letters or more
  • No disqualifying lesions.

AMD Category 2.

At least one eye has one or more intermediate drusen, extensive small drusen, or pigment abnormalities associated with AMD, and neither eye has:

  • Large drusen
  • Advanced AMD
  • A visual acuity score of 73 or less
  • A disqualifying lesion.

AMD Category 3.

There are two types of AMD Category 3 participants.

  1. At least one eye has one or more of the following:
  • One or more large drusen
  • Intermediate drusen, with total drusen area
    • At least that of Circle I-2 (i.e., about 20 average-size intermediate drusen) if soft indistinct drusen are present or
    • At least that of Circle O-2 (i.e., about 1/5 disc area, or about 65 average-size intermediate drusen) if soft indistinct drusen are absent
  • Definite geographic atrophy not involving the center of the macula, and neither eye has any of the following:
    • Advanced AMD
    • A visual acuity score of 73 letters or less
    • A disqualifying lesion. or
  1. Only one eye meets the criteria specified above in part
  • and the fellow eye has either of the following:
    • A visual acuity score of 73 or less not attributable to AMD, or
    • A disqualifying lesion (listed in Section 3.1.3.2) considered to be uniocular.

AMD Category 4.

There are two types of AMD Category 4 participants.

  1. One eye has advanced AMD with or without visual acuity score of 73 or less, and with or without a disqualifying lesion considered to be uniocular, and the fellow eye has:
  • A visual acuity score of 74 or more
  • No evidence of advanced AMD
  • No disqualifying lesion. or
  1. One eye has reduced vision (< 74 letters) due to AMD, but no evidence of advanced AMD, and the fellow eye has:
  • A visual acuity score of 74 or more
  • No evidence of advanced AMD
  • No disqualifying lesion.

NIH AREDS Labelling Scheme

Ref: ncbi.nlm.nih.gov

  • Large Drusen: Large drusen (≥ 125 microns in diameter) in at least one eye at the last study visit and in at least one other study visit (in the same eye).
  • Large Drusen Questionable 1: Large drusen in at least one eye at 2 or more visits (other than the last visit).
  • Large Drusen Questionable 2: Large drusen in at least one eye only at the last study visit. This includes participants who only have a baseline visit if one or both eyes have large drusen.
  • Large Drusen Questionable 3: Large drusen in at least one eye at just one study visit (other than the last visit).
  • Control: AMD Category 1 (no drusen or small [< 63 microns in diameter] non-extensive drusen) in both eyes at all visits. This includes participants who only have a baseline visit if both eyes were graded as AMD Category 1.
  • Control Questionable 1: AMD Category 1 in both eyes at last visit and at all previous visits, except that one eye is AMD Category 2 (non-extensive intermediate [(≥ 63 microns to < 125 microns in diameter] drusen or extensive small drusen) at one visit.
  • Control Questionable 2: AMD Category 1 in both eyes at last visit and at all previous visits, except that each eye is AMD Category 2 at one visit.
  • Control Questionable 3: AMD Category 1 in both eyes at last visit, no worse than AMD Category 2 in either eye at all other visits, at least one eye is Category 2 at 2 or more visits prior to last visit.
  • Control Questionable 4: AMD Category 1 in one eye at last visit and AMD Category 2 in fellow eye at last visit; AMD Category 1 at all other visits. Participant must have at least one visit postbaseline.
  • Other, Non-control: Does not meet any of the criteria of categories noted above.

About

Age-Related Macular Degeneration (AMD) Research using AREDS dataset provided by National Institute of Health (NIH).

Topics

Resources

Stars

Watchers

Forks

Releases

No releases published

Packages

No packages published